PCV16 COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75381-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)75381-X/fulltext
Title :
PCV16 COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75381-X&doi=10.1016/S1098-3015(10)75381-X
First page :
Section Title :
Open access? :
No
Section Order :
1310